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Introduction
Procalcitonin (PCT) is a recently described marker of
severe sepsis. It was decided to assess the value of PCT
as a marker of secondary infection in patients infected
with HIV in Georgian AIDS Center.
Materials and methods
PCT plasma levels were measured by quantitative assay
BRAHMS-Biomérieux using the VIDAS analyser in a
prospective study in 135 HIV-infected individuals: 87
asymptomatic and 48 with lever or suspected secondary
infections.
Results
The baseline plasma level of PCT was (0.5 ng/ml +/- 0.5),
even in the latest stages of the disease, and did not differ
from the values of healthy subjects (0.54 ng/ml +/- 0.1).
EDTA-treated whole blood was collected from patients
before starting specific antimicrobial therapy. No eleva-
tion of PCT level was detected in HIV-infected patients
with evolving secondary infections including PCP (n = 4),
cerebral toxoplasmosis (n = 5), viral infections (n = 9),
mycobacterial infections (n = 4), localized bacterial (n =
13) and fungal infections (n = 4), and in various asso-
ciated infectious and non-infectious febrile events (n =
15). All these plasma values were lower than 2 ng/ml. In
contrast, high PCT plasma levels were detected in one
HIV-infected patient with a septicaemic influenza infec-
tion (17 ng/ml) and another one with a septicaemic
Pneudomonas aeruginosa infection (46 ng/ ml), PCT
values decreased rapidly under appropriate therapy.
Conclusions
We found that PCT is a specific marker of bacterial sep-
sis in HIV-infected patients, as no increase in other sec-
ondary infections could be detected in those patients. A
rapid determination of PCT level could be useful to ver-
ify or refute bacterial sepsis for a better management of
febrile HIV-infected patients.
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